| Skin and Soft Tissue Infection |
1 |
1 |
| Vagina |
0 |
1 |
| Vaginal Discharge |
0 |
0.67 |
| Microbiome |
0 |
0.52 |
| Patient Safety |
0 |
0.47 |
| Vaginitis |
0 |
0.42 |
| Bacterial Vaginosis |
0 |
0.28 |
| Adolescent Medicine |
0 |
0.21 |
| Biologic Therapy |
0 |
0.17 |
| Bacteria |
0 |
0.14 |
| Epithelium |
0 |
0.1 |
| Fungal Infection |
0 |
0.1 |
| Pruritus |
0 |
0.1 |
| Social Determinants of Health |
0 |
0.1 |
| Urinary Tract Infection |
0 |
0.1 |
| Adverse Effects |
0 |
0.05 |
| Blood |
0 |
0.05 |
| Canada |
0 |
0.05 |
| Candidiasis |
0 |
0.05 |
| Face |
0 |
0.05 |
| Gardnerella |
0 |
0.05 |
| Interleukin |
0 |
0.05 |
| Racism |
0 |
0.05 |
| Sexually Transmitted Infection |
0 |
0.05 |
| Tissue |
0 |
0.05 |
| UK Site Content |
0 |
0.05 |